159 related articles for article (PubMed ID: 6997299)
1. Adenosine deaminase impairment and ribonucleotide reductase activity and levels in HeLa cells.
Lin AL; Elford HL
J Biol Chem; 1980 Sep; 255(18):8523-8. PubMed ID: 6997299
[TBL] [Abstract][Full Text] [Related]
2. Adenosine deaminase impairment and ribonucleotide reductase in human cells.
Elford HL; Lin AL
Ann N Y Acad Sci; 1985; 451():98-112. PubMed ID: 3907454
[No Abstract] [Full Text] [Related]
3. Effects of deoxyadenosine on ribonucleotide reductase in adenosine deaminase-deficient lymphocytes.
Takeda E; Kuroda Y; Naito E; Yokota I; Saijo T; Hirose M; Miyao M
J Inherit Metab Dis; 1991; 14(1):87-95. PubMed ID: 1830628
[TBL] [Abstract][Full Text] [Related]
4. Purinogenic immunodeficiency diseases. Differential effects of deoxyadenosine and deoxyguanosine on DNA synthesis in human T lymphoblasts.
Wilson JM; Mitchell BS; Daddona PE; Kelley WN
J Clin Invest; 1979 Nov; 64(5):1475-84. PubMed ID: 115901
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a cultured human T-cell line with genetically altered ribonucleotide reductase activity. Model for immunodeficiency.
Waddell D; Ullman B
J Biol Chem; 1983 Apr; 258(7):4226-31. PubMed ID: 6339493
[TBL] [Abstract][Full Text] [Related]
6. Increased level of ribonucleotide reductase in deoxyadenosine resistant adenosine deaminase deficient human histiocytic lymphoma cells.
Dahbo Y; Carson D; Eriksson S
Adv Exp Med Biol; 1986; 195 Pt B():231-4. PubMed ID: 3532701
[No Abstract] [Full Text] [Related]
7. Deoxyadenosine triphosphate as a potentially toxic metabolite in adenosine deaminase deficiency.
Cohen A; Hirschhorn R; Horowitz SD; Rubinstein A; Polmar SH; Hong R; Martin DW
Proc Natl Acad Sci U S A; 1978 Jan; 75(1):472-6. PubMed ID: 272665
[TBL] [Abstract][Full Text] [Related]
8. The mechanism of inhibition and "reversal" of mitogen-induced lymphocyte activation in a model of adenosine deaminase deficiency.
Albert D; Bluestein HG; Thompson L; Seegmiller JE
Cell Immunol; 1984 Jul; 86(2):510-7. PubMed ID: 6610485
[TBL] [Abstract][Full Text] [Related]
9. Effect of ribonucleotide reductase inhibitors on the growth of human colon carcinoma HT-29 cells in culture.
Matsumoto M; Tihan T; Cory JG
Cancer Chemother Pharmacol; 1990; 26(5):323-9. PubMed ID: 2208572
[TBL] [Abstract][Full Text] [Related]
10. Antineoplastic effect of the combination of 2,3-dihydro-1H-pyrazole[2,3a]imidazole plus deoxyadenosine/erythro-9-(2-hydroxyl-3-nonyl)adenine in mice with L1210 leukemia cells.
Matsumoto M; Weckbecker G; Cory JG
Cancer Commun; 1990; 2(1):1-6. PubMed ID: 2369548
[TBL] [Abstract][Full Text] [Related]
11. Leukemia L1210 cell lines resistant to ribonucleotide reductase inhibitors.
Cory JG; Carter GL
Cancer Res; 1988 Feb; 48(4):839-43. PubMed ID: 3276399
[TBL] [Abstract][Full Text] [Related]
12. Deoxynucleoside overproduction in deoxyadenosine-resistant, adenosine deaminase-deficient human histiocytic lymphoma cells.
Kubota M; Carrera CJ; Wasson DB; Carson DA
Biochim Biophys Acta; 1984 May; 804(1):37-43. PubMed ID: 6372866
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of an aminohydrolase distinct from adenosine deaminase in cultured human lymphoblasts.
Daddona PE; Kelley WN
Biochim Biophys Acta; 1981 Apr; 658(2):280-90. PubMed ID: 6972784
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the residual adenosine deaminating activity in the spleen of a patient with combined immunodeficiency disease and adenosine deaminase deficiency.
Schrader WP; Pollara B; Meuwissen HJ
Proc Natl Acad Sci U S A; 1978 Jan; 75(1):446-50. PubMed ID: 24216
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of deoxyadenosine-induced catabolism of adenine ribonucleotides in adenosine deaminase-inhibited human T lymphoblastoid cells.
Bagnara AS; Hershfield MS
Proc Natl Acad Sci U S A; 1982 Apr; 79(8):2673-7. PubMed ID: 6283540
[TBL] [Abstract][Full Text] [Related]
16. A role for purine metabolism in the immune response: Adenosine-deaminase activity and deoxyadenosine catabolism.
Simmonds HA; Panayi GS; Corrigall V
Lancet; 1978 Jan; 1(8055):60-3. PubMed ID: 74565
[TBL] [Abstract][Full Text] [Related]
17. Erythro-9-(2-hydroxy-3-nonyl)adenine as a specific inhibitor of herpes simplex virus replication in the presence and absence of adenosine analogues.
North TW; Cohen SS
Proc Natl Acad Sci U S A; 1978 Oct; 75(10):4684-8. PubMed ID: 216993
[TBL] [Abstract][Full Text] [Related]
18. Deoxyadenosine reverses hydroxyurea inhibition of vaccinia virus growth.
Slabaugh MB; Howell ML; Wang Y; Mathews CK
J Virol; 1991 May; 65(5):2290-8. PubMed ID: 2016760
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of deoxyadenosine toxicity in human lymphoid cells in vitro: relevance to the therapeutic use of inhibitors of adenosine deaminase.
Lee N; Russell N; Ganeshaguru K; Jackson BF; Piga A; Prentice HG; Foa R; Hoffbrand AV
Br J Haematol; 1984 Jan; 56(1):107-19. PubMed ID: 6231047
[TBL] [Abstract][Full Text] [Related]
20. Adenosine uptake and deamination regulate tonic A2a receptor facilitation of evoked [3H]acetylcholine release from the rat motor nerve terminals.
Correia-de-Sá P; Ribeiro JA
Neuroscience; 1996 Jul; 73(1):85-92. PubMed ID: 8783232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
